Prot# GS-US-418-3898: Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Coliti
- Hanauer, Stephen B (PD/PI)
Project: Research project